normal phenotype
• no abnormalities are detected in mice
|
Allele Symbol Allele Name Allele ID |
Tsc2tm1Kido targeted mutation 1, Yoshiaki Kido MGI:3795269 |
||||||||||||
Summary |
2 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• no abnormalities are detected in mice
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• in a fed state from 4 until 32 weeks of age
|
• after 36 week of age, mice exhibit increased plasma glucose levels compared to wild-type mice
• however, treatment of mice with rapamycin prevents the development of hyperglycemia
|
• after 40 weeks of age
• however, treatment of mice with rapamycin prevents the decrease in plasma insulin levels
|
• at 12 weeks of age until 32 weeks
|
• at 8 weeks of age
|
• at 8 weeks of age
|
• at 40 weeks of age, islet cell density is decreased compared to in wild-type mice
|
• at 6 weeks of age, beta cell mass and size is increased compared to in wild-type mice
• at 40 weeks of age, beta cell mass decreases to lower than normal
• however, the number of beta cells is normal
• beta cell size is not decreased after 40 weeks of age
|
• at 40 weeks of age, beta cell number is decreased due to apoptosis
• however, treatment of mice with rapamycin prevents the decrease in beta cell mass observed at 40 weeks of age
|
• at 6 weeks of age
|
• after 48 weeks of age
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|